Incretin & Metabolic Receptor Agonists
Retatrutide
Also known as LY3437943
Late-stage human trialsInvestigational
Last reviewed: 2026-11-19
Class & structure
A 39-amino-acid chain.
How it’s thought to work
Activates GIP, GLP-1 and glucagon receptors; their combined effects are studied in controlled trials.
Key sources
Identity and editorial screen completed November 19, 2026. Previously checked primary references retained; this is not an exhaustive clinical review.
Related compounds
- Semaglutide
Same scientific class · A 31-amino-acid chain. · FDA-approved for specific indications
- Tirzepatide
Same scientific class · A 39-amino-acid chain. · FDA-approved for specific indications